Further, in our RNA-sequencing data we have observed that FOXM1 inhibition is increasing the expression of inflammatory cytokines (IL24, CXCL8, CCL3, CCL3P1 and CCL3L3) in the SCLC cells which can in turn activate cytotoxic T cells (Fig. 6A). Here, FOXM1 is linked to small cell lung carcinoma.